470 related articles for article (PubMed ID: 25057956)
1. Clinical significance of autoantibodies in primary biliary cirrhosis.
Nakamura M
Semin Liver Dis; 2014 Aug; 34(3):334-40. PubMed ID: 25057956
[TBL] [Abstract][Full Text] [Related]
2. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
Nakamura M; Kondo H; Mori T; Komori A; Matsuyama M; Ito M; Takii Y; Koyabu M; Yokoyama T; Migita K; Daikoku M; Abiru S; Yatsuhashi H; Takezaki E; Masaki N; Sugi K; Honda K; Adachi H; Nishi H; Watanabe Y; Nakamura Y; Shimada M; Komatsu T; Saito A; Saoshiro T; Harada H; Sodeyama T; Hayashi S; Masumoto A; Sando T; Yamamoto T; Sakai H; Kobayashi M; Muro T; Koga M; Shums Z; Norman GL; Ishibashi H
Hepatology; 2007 Jan; 45(1):118-27. PubMed ID: 17187436
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significance.
Yamagiwa S; Kamimura H; Takamura M; Aoyagi Y
World J Gastroenterol; 2014 Mar; 20(10):2606-12. PubMed ID: 24627596
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease.
Gatselis NK; Zachou K; Norman GL; Gabeta S; Papamichalis P; Koukoulis GK; Dalekos GN
Autoimmunity; 2013 Nov; 46(7):471-9. PubMed ID: 23777462
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
[TBL] [Abstract][Full Text] [Related]
6. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
[TBL] [Abstract][Full Text] [Related]
7. [How to understand the clinical significance of autoantibodies in primary biliary cholangitis].
Yan HP; Zhang HP; Chen XX
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):810-815. PubMed ID: 29325273
[TBL] [Abstract][Full Text] [Related]
8. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].
Xiao H; Chen JW; Xie X; Liu YM; Li F
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):209-14. PubMed ID: 22516989
[TBL] [Abstract][Full Text] [Related]
10. Is prevalence of PBC underestimated in patients with systemic sclerosis?
Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune tests in primary biliary cirrhosis.
Strassburg CP; Manns MP
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):585-99. PubMed ID: 10976016
[TBL] [Abstract][Full Text] [Related]
12. Antimitochondrial antibodies in primary biliary cirrhosis.
Leung PS; Coppel RL; Ansari A; Munoz S; Gershwin ME
Semin Liver Dis; 1997 Feb; 17(1):61-9. PubMed ID: 9089911
[TBL] [Abstract][Full Text] [Related]
13. The immunopathogenesis of primary biliary cirrhosis.
Quaranta S; Van de Water J; Ishibashi H; Rosina F; Coppel R; Uibo R; Gershwin ME
Hepatogastroenterology; 1999; 46(30):3041-7. PubMed ID: 10626157
[TBL] [Abstract][Full Text] [Related]
14. Breach of tolerance: primary biliary cirrhosis.
Wang L; Wang FS; Chang C; Gershwin ME
Semin Liver Dis; 2014 Aug; 34(3):297-317. PubMed ID: 25057953
[TBL] [Abstract][Full Text] [Related]
15. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells.
Gershwin ME; Ansari AA; Mackay IR; Nakanuma Y; Nishio A; Rowley MJ; Coppel RL
Immunol Rev; 2000 Apr; 174():210-25. PubMed ID: 10807518
[TBL] [Abstract][Full Text] [Related]
16. Primary biliary cirrhosis: overlaps with other autoimmune disorders.
Floreani A; Franceschet I; Cazzagon N
Semin Liver Dis; 2014 Aug; 34(3):352-60. PubMed ID: 25057958
[TBL] [Abstract][Full Text] [Related]
17. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
18. The natural history of primary biliary cirrhosis.
Imam MH; Lindor KD
Semin Liver Dis; 2014 Aug; 34(3):329-33. PubMed ID: 25057955
[TBL] [Abstract][Full Text] [Related]
19. Role of autoantibodies in the clinical management of primary biliary cholangitis.
Rigopoulou EI; Bogdanos DP
World J Gastroenterol; 2023 Mar; 29(12):1795-1810. PubMed ID: 37032725
[TBL] [Abstract][Full Text] [Related]
20. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.
Assassi S; Fritzler MJ; Arnett FC; Norman GL; Shah KR; Gourh P; Manek N; Perry M; Ganesh D; Rahbar MH; Mayes MD
J Rheumatol; 2009 Oct; 36(10):2250-6. PubMed ID: 19723904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
